drugset / Trial / NCT03131726

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

NCT03131726

Phase 3 Recruiting 80 enrolled Lund University Region Skane · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

In an investigator initiated multicenter trial (Malmö, Odense, Århus) the investigators aim at evaluating activity of Graves´ophthalmopathy (GO) and progress to severe GO in patients with mild to moderate Graves´ ophthalmopathy treated with simvastatin or no treatment.

Timeline

Start
2018-01-26
Primary completion
2027-01-26
Completion
2028-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 40 mg